1. Home
  2. KEQU vs MOLN Comparison

KEQU vs MOLN Comparison

Compare KEQU & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$34.45

Market Cap

106.3M

Sector

Industrials

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.18

Market Cap

170.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
MOLN
Founded
1906
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
106.3M
170.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
KEQU
MOLN
Price
$34.45
$4.18
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
1.6K
1.2K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.22
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$374.07
P/E Ratio
$10.88
N/A
Revenue Growth
7.72
N/A
52 Week Low
$33.27
$3.53
52 Week High
$46.70
$5.36

Technical Indicators

Market Signals
Indicator
KEQU
MOLN
Relative Strength Index (RSI) 33.70 48.08
Support Level $33.49 $4.13
Resistance Level $35.35 $4.19
Average True Range (ATR) 0.95 0.07
MACD -0.30 -0.03
Stochastic Oscillator 34.29 18.33

Price Performance

Historical Comparison
KEQU
MOLN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: